Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure 
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation 
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Oil Prices Hold Steady as Ukraine Tensions and Fed Cut Expectations Support Market 
Austria’s AA Credit Rating Affirmed as Fitch Highlights Stable Outlook 
Trump Meets Mexico and Canada Leaders After 2026 World Cup Draw Amid USMCA Tensions 
Boeing Acquisition of Spirit AeroSystems Could Close Soon Amid Ongoing Conditions 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
